Winsor Bowsher (deceased), Department of Urology, St. Joseph's Hospital, NewportAdam Carter, Department of Urology, Royal Gwent Hospital, Newport

"Currently there are more questions than answers in prostate cancer and the authors certainly could not have been expected to provide all the solutions for these many difficult issues. They have set out the problems clearly, however, and by doing so set a challenge for all of us in the urological community to provide the evidence based resolution to these many thorny issues by carefully constructed, long-term randomised files."British Journal of Urology "...contains useful information and is a helpful resource for understanding many of the controversies in this area."The Lancet

• List of contributors. Part 1: Biological and Scientific Aspects.1 Tim Lane, Jon Strefford and Tim Oliver.An Update on Biotechnology in the Assessment of Prostate Cancer.2 Ludger Barthelmes and Christopher A. Gateley.What Can We Learn From Breast Cancer?.3 Bernhard Brehmer, Antonio Smakris and Gerhard Jakse.New Serum Markers for Prostate Cancer.4 Kenichiro Ishii and Simon Hayward.The History of Tissue Recombination Technology: Current and Future Research.5 Malcolm Mason and John Staffurth.Why We Cannot Use the Results of Non-Randomised Trials to Inform Us About Treatment for Early Prostate Cancer?.Part 2: Diagnosis and Evaluation.6 Bob Djavan, Michael Dobrovits and Michael Marberger.Equivocal PSAResults and Free Total PSARatio.7 Murali Varma And David Griffiths .Equivocal Prostate Needle Biopsies.8 Richard Clements.Prostate Biopsy: How Many Cores and Where From?.9 Gail Beese and Christopher Edmunds.Counselling Patients With Early Prostate Cancer.10 Owen Niall and Jamie Kearsley.The Role of Pelvic Node Dissection in Prostate Cancer.Part 3: Initial Treatment Policies.11 Mark Wright.Laparoscopic Radical Prostatectomy.12 A. Goyal and W. Bowsher.Endocrine Therapy for Prostate Cancer: the Latest.13 Stijn De Vries, Christopher Bangma and Fritz Schröder.The Role of Conservative Policies in the Treatment of Prostate Cancer.14 Gary Deng and Barrie Cassileth.Complementary and Alternative Therapies for Prostate Cancer.Part 4: Monitoring Progress and SecondaryTreatment.15 Amir Kaisary.Radical Prostatectomy After Radical Radiotherapy.16 Paul Jones and Neil Fenn.Treatment of Renal Impairment Secondary to Locally Advanced Prostate Cancer.17 Robert P. Myers, R. Houston Thompson, Stephen M. Schatz and Michael L. Blute.Open Radical Prostatectomy: How Can Intra-operative, Peri-operative and Post-operative Complications Be Prevented?.18 Leslie Moffat.Documenting Prostate Cancer: Epidemiology and Treatment.19 Steven Oliver, Rhidian Hurle and Owen Hughes.Trends in Prostate Cancer Incidence and Mortality.20 Jason Lester and E M Mahudson.Chemotherapy in Prostate Cancer.Index.Colour plates

Winsor Bowsher (deceased), Department of Urology, St. Joseph's Hospital, NewportAdam Carter, Department of Urology, Royal Gwent Hospital, Newport

"Currently there are more questions than answers in prostate cancer and the authors certainly could not have been expected to provide all the solutions for these many difficult issues. They have set out the problems clearly, however, and by doing so set a challenge for all of us in the urological community to provide the evidence based resolution to these many thorny issues by carefully constructed, long-term randomised files."British Journal of Urology "...contains useful information and is a helpful resource for understanding many of the controversies in this area."The Lancet

• List of contributors. Part 1: Biological and Scientific Aspects.1 Tim Lane, Jon Strefford and Tim Oliver.An Update on Biotechnology in the Assessment of Prostate Cancer.2 Ludger Barthelmes and Christopher A. Gateley.What Can We Learn From Breast Cancer?.3 Bernhard Brehmer, Antonio Smakris and Gerhard Jakse.New Serum Markers for Prostate Cancer.4 Kenichiro Ishii and Simon Hayward.The History of Tissue Recombination Technology: Current and Future Research.5 Malcolm Mason and John Staffurth.Why We Cannot Use the Results of Non-Randomised Trials to Inform Us About Treatment for Early Prostate Cancer?.Part 2: Diagnosis and Evaluation.6 Bob Djavan, Michael Dobrovits and Michael Marberger.Equivocal PSAResults and Free Total PSARatio.7 Murali Varma And David Griffiths .Equivocal Prostate Needle Biopsies.8 Richard Clements.Prostate Biopsy: How Many Cores and Where From?.9 Gail Beese and Christopher Edmunds.Counselling Patients With Early Prostate Cancer.10 Owen Niall and Jamie Kearsley.The Role of Pelvic Node Dissection in Prostate Cancer.Part 3: Initial Treatment Policies.11 Mark Wright.Laparoscopic Radical Prostatectomy.12 A. Goyal and W. Bowsher.Endocrine Therapy for Prostate Cancer: the Latest.13 Stijn De Vries, Christopher Bangma and Fritz Schröder.The Role of Conservative Policies in the Treatment of Prostate Cancer.14 Gary Deng and Barrie Cassileth.Complementary and Alternative Therapies for Prostate Cancer.Part 4: Monitoring Progress and SecondaryTreatment.15 Amir Kaisary.Radical Prostatectomy After Radical Radiotherapy.16 Paul Jones and Neil Fenn.Treatment of Renal Impairment Secondary to Locally Advanced Prostate Cancer.17 Robert P. Myers, R. Houston Thompson, Stephen M. Schatz and Michael L. Blute.Open Radical Prostatectomy: How Can Intra-operative, Peri-operative and Post-operative Complications Be Prevented?.18 Leslie Moffat.Documenting Prostate Cancer: Epidemiology and Treatment.19 Steven Oliver, Rhidian Hurle and Owen Hughes.Trends in Prostate Cancer Incidence and Mortality.20 Jason Lester and E M Mahudson.Chemotherapy in Prostate Cancer.Index.Colour plates

Winsor Bowsher (deceased), Department of Urology, St. Joseph's Hospital, NewportAdam Carter, Department of Urology, Royal Gwent Hospital, Newport

"Currently there are more questions than answers in prostate cancer and the authors certainly could not have been expected to provide all the solutions for these many difficult issues. They have set out the problems clearly, however, and by doing so set a challenge for all of us in the urological community to provide the evidence based resolution to these many thorny issues by carefully constructed, long-term randomised files."British Journal of Urology "...contains useful information and is a helpful resource for understanding many of the controversies in this area."The Lancet

• List of contributors. Part 1: Biological and Scientific Aspects.1 Tim Lane, Jon Strefford and Tim Oliver.An Update on Biotechnology in the Assessment of Prostate Cancer.2 Ludger Barthelmes and Christopher A. Gateley.What Can We Learn From Breast Cancer?.3 Bernhard Brehmer, Antonio Smakris and Gerhard Jakse.New Serum Markers for Prostate Cancer.4 Kenichiro Ishii and Simon Hayward.The History of Tissue Recombination Technology: Current and Future Research.5 Malcolm Mason and John Staffurth.Why We Cannot Use the Results of Non-Randomised Trials to Inform Us About Treatment for Early Prostate Cancer?.Part 2: Diagnosis and Evaluation.6 Bob Djavan, Michael Dobrovits and Michael Marberger.Equivocal PSAResults and Free Total PSARatio.7 Murali Varma And David Griffiths .Equivocal Prostate Needle Biopsies.8 Richard Clements.Prostate Biopsy: How Many Cores and Where From?.9 Gail Beese and Christopher Edmunds.Counselling Patients With Early Prostate Cancer.10 Owen Niall and Jamie Kearsley.The Role of Pelvic Node Dissection in Prostate Cancer.Part 3: Initial Treatment Policies.11 Mark Wright.Laparoscopic Radical Prostatectomy.12 A. Goyal and W. Bowsher.Endocrine Therapy for Prostate Cancer: the Latest.13 Stijn De Vries, Christopher Bangma and Fritz Schröder.The Role of Conservative Policies in the Treatment of Prostate Cancer.14 Gary Deng and Barrie Cassileth.Complementary and Alternative Therapies for Prostate Cancer.Part 4: Monitoring Progress and SecondaryTreatment.15 Amir Kaisary.Radical Prostatectomy After Radical Radiotherapy.16 Paul Jones and Neil Fenn.Treatment of Renal Impairment Secondary to Locally Advanced Prostate Cancer.17 Robert P. Myers, R. Houston Thompson, Stephen M. Schatz and Michael L. Blute.Open Radical Prostatectomy: How Can Intra-operative, Peri-operative and Post-operative Complications Be Prevented?.18 Leslie Moffat.Documenting Prostate Cancer: Epidemiology and Treatment.19 Steven Oliver, Rhidian Hurle and Owen Hughes.Trends in Prostate Cancer Incidence and Mortality.20 Jason Lester and E M Mahudson.Chemotherapy in Prostate Cancer.Index.Colour plates